<DOC>
	<DOCNO>NCT01679847</DOCNO>
	<brief_summary>The purpose study elucidate pharmacokinetics blood-brain barrier penetration elemene .</brief_summary>
	<brief_title>Blood Brain Barrier Penetration Pharmacokinetics Elemene Malignant Patients .</brief_title>
	<detailed_description />
	<criteria>histopathological cytopathology diagnosis malignancy heart , liver renal function normal Expected survival time 3 month Signed informed consent exclusion Criteria : non cancer patient accept elemene administration 1 month Expected survival time le 3 month Signed informed consent heart , liver renal function abnormal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Elemene</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Blood-brain barrier</keyword>
</DOC>